Results 171 to 180 of about 11,802 (200)
Some of the next articles are maybe not open access.
Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United States
Microbial Drug Resistance, 2022Carbapenem-resistant Enterobacterales (CRE) are a growing public health concern due to resistance to multiple antibiotics and potential to cause health care-associated infections with high mortality. Carbapenemase-producing CRE are of particular concern given that carbapenemase-encoding genes often are located on mobile genetic ...
Adrian Lawsin +2 more
exaly +3 more sources
Clinical and genomic characterization of carbapenem-resistant Enterobacterales bloodstream infections in patients with hematologic malignancies [PDF]
Frontiers in Cellular and Infection MicrobiologyBackgroundCarbapenem-resistant Enterobacterales (CRE) bloodstream infections (BSIs) pose a significant risk to patients with hematologic malignancies, yet the distinct features and outcomes of these infections are not thoroughly understood.MethodsThis ...
Jiangqing Huang +2 more
exaly +2 more sources
Predictors of Resistance to Ceftazidime-Avibactam in Carbapenem-Resistant Enterobacterales
Infectious Diseases in Clinical Practice, 2022Background Ceftazidime-avibactam (CAZ-AVI) is a safe and effective treatment option for carbapenem-resistant Enterobacterales (CRE). However, predictors of resistance to CAZ-AVI have not been well defined. Therefore, our study describes risk factors for resistance to CAZ-AVI in hospitalized patients with CRE infections.
Tae Eun Park +6 more
openaire +1 more source
The epidemiology of carbapenem-resistant Enterobacterales in a single center in Oman
International Journal of Infection Control, 2023Background: Carbapenem-resistant Enterobacterales (CRE) are a global public health threat associated with significant morbidity and mortality. Objectives: The study aims to describe the epidemiology, microbiology and outcome of patients with CRE infection or colonization during an active surveillance program and to determine the risk factors for the ...
Ahmed AL Yarabi +5 more
openaire +1 more source
Carbapenem-resistant Enterobacterales (CRE): The storm is coming
Intensive and Critical Care Nursing, 2023Zahar, Jean-Ralph, Blot, Stijn
openaire +4 more sources
Reviewing novel treatment options for carbapenem-resistant Enterobacterales
Expert Review of Anti-infective TherapyCarbapenem resistant Enterobacterales (CRE) are a major threat to global health and hospital-onset CRE infections have risen during the COVID-19 pandemic. Novel antimicrobials are now available for the treatment of CRE infections. There remains an urgent need for new antimicrobials for CRE, especially for those producing metallo-β-lactamases.This ...
Natalie A, Mackow, David, van Duin
openaire +2 more sources
Carbapenem-resistant Enterobacterales in the USA
The Lancet Infectious Diseases, 2020Sumanth, Gandra, Carey-Ann D, Burnham
openaire +2 more sources